MondegarAI
Beryl Capital Management LLC

Q1 2025 · 13F-HR

Beryl Capital Management LLCholdings as filed

Filed 2025-05-15 · accession 0001719307-25-000003

$267.7M
Reported value
13
Positions
2025-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
46116X101ITCIEURINTRA-CELLULAR THERAPIES INC$71.5M26.7%541,642CommonSOLE
073685109BECNUSDBEACON ROOFING SUPPLY INC$50.0M18.7%404,476CommonSOLE
16934W106CMRXEURCHIMERIX INC$33.4M12.5%3,927,238CommonSOLE
162828206CHECKPOINT THERAPEUTICS INC$24.5M9.17%6,074,216CommonSOLE
26484T106DNBDUN & BRADSTREET HLDGS INC$22.6M8.43%2,522,484CommonSOLE
64157F103NVROEURNEVRO CORP$22.0M8.21%3,761,191CommonSOLE
901384107TSVT*2SEVENTY BIO INC$21.0M7.84%4,250,000CommonSOLE
029683109AMSWAUSDLOGILITY SUPPLY CHAIN SOLUTI$13.6M5.06%950,672CommonSOLE
531914109LWAYLIFEWAY FOODS INC$4.7M1.77%193,888CommonSOLE
703395103PDCOEURPATTERSON COS INC$3.2M1.21%103,701CommonSOLE
88080T104WULFTERAWULF INC$691,8640.26%253,430CommonSOLE
784933103SGRPSPAR GROUP INC$370,1930.14%280,449CommonSOLE
91854V206VACASA INC$101,6600.04%18,896CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.